Showing results (131-140 of 151) with videos related to

Sort By:
Pageof 16
Frontiers in Cell and Developmental Biology|April 11, 2022
AZD5153, a Bivalent BRD4 Inhibitor, Suppresses Hepatocarcinogenesis by Altering BRD4 Chromosomal Landscape and Modulating the Transcriptome of HCC CellsCho-Hao Lin, Jimmy Chun-Tien Kuo, Ding Li, et al.
Molecular Biology of the Cell|January 30, 2015
Ploidy variation in multinucleate cells changes under stressCori A Anderson, Samantha Roberts, Huaiying Zhang, et al.
The American Review of Respiratory Disease|August 1, 1992
Disordered pathways of fibrin turnover in lung lavage of premature infants with respiratory distress syndromeR M Viscardi, K Broderick, C C Sun, et al.
Clinical and Translational Medicine|June 9, 2016
Organizing empyema induced in mice by Streptococcus pneumoniae: effects of plasminogen activator inhibitor-1 deficiencyTorry A Tucker, Ann Jeffers, Jake Boren, et al.
Animals : an Open Access Journal From MDPI|December 17, 2024
A Pilot Study to Assess the Safety and Efficacy of Umbilical Cord Blood-Derived Mesenchymal Stromal Cells for the Treatment of Synovitis in HorsesKathryn Seabaugh, Sangeeta Rao, Judith B Koenig, et al.
The American Journal of Pathology|October 28, 2017
Inhibition of Glycogen Synthase Kinase 3β Blocks Mesomesenchymal Transition and Attenuates Streptococcus pneumonia-Mediated Pleural Injury in MiceJake Boren, Grant Shryock, Alexis Fergis, et al.
Molecular and Cellular Biology|September 1, 1994
Characterization and cloning of a receptor for BMP-2 and BMP-4 from NIH 3T3 cellsB B Koenig, J S Cook, D H Wolsing, et al.
Cancer Chemotherapy and Pharmacology|October 12, 2012
Phase I trial of exemestane in combination with metformin and rosiglitazone in nondiabetic obese postmenopausal women with hormone receptor-positive metastatic breast cancerFrancisco J Esteva, Stacy L Moulder, Ana M Gonzalez-Angulo, et al.
The Oncologist|November 3, 2020
A Randomized Phase II Study of Sequential Eribulin Versus Paclitaxel Followed by FAC/FEC as Neoadjuvant Therapy in Patients with Operable HER2-Negative Breast CancerBora Lim, Juhee Song, Nuhad K Ibrahim, et al.
Journal of Cancer|August 19, 2017
Rapid Breast Cancer Disease Progression Following Cyclin Dependent Kinase 4 and 6 Inhibitor DiscontinuationSami I Bashour, Iman Doostan, Khandan Keyomarsi, et al.
Pageof 16